Alcohol Withdrawal Management Protocol
Benzodiazepines are the gold standard first-line treatment for alcohol withdrawal syndrome, with symptom-triggered dosing preferred over fixed schedules, and all patients must receive thiamine supplementation to prevent Wernicke encephalopathy. 1
Initial Assessment and Risk Stratification
Use the CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol) scale to assess withdrawal severity 1:
- CIWA-Ar score >8: Moderate withdrawal requiring pharmacological treatment
- CIWA-Ar score ≥15: Severe withdrawal requiring intensive management
Important caveat: CIWA-Ar is useful for monitoring treatment but should NOT be used alone for diagnosis, as high scores can occur in other conditions (anxiety disorders, sepsis, hepatic encephalopathy, severe pain) 2
Indications for Inpatient vs Outpatient Management
Admit to hospital if any of the following are present 2:
- History of withdrawal seizures or delirium tremens
- Significant AWS with CIWA-Ar ≥15
- High levels of recent drinking
- Serious medical comorbidities (liver failure, respiratory failure, recent head trauma)
- Serious psychiatric comorbidities
- Failed outpatient treatment
- Lack of adequate social support
Outpatient management is appropriate for mild-to-moderate withdrawal without these risk factors 2, 3
Pharmacological Treatment Protocol
Benzodiazepine Selection and Dosing
For most patients (without liver disease):
For patients with liver failure, advanced age, respiratory failure, or obesity:
- Lorazepam (intermediate-acting) is safer due to no active metabolites 2, 1
- Starting dose: 6-12 mg/day divided into 1-4 mg every 4-8 hours 2
- Taper following resolution of withdrawal symptoms
Dosing strategy: Use symptom-triggered regimens rather than fixed-dose schedules to prevent drug accumulation 1
Duration: Limit benzodiazepines to 10-14 days maximum due to abuse potential 1
Essential Thiamine Supplementation
All patients with alcohol withdrawal MUST receive thiamine 2:
- Prevention of Wernicke encephalopathy: 100-300 mg/day for 4-12 weeks 2
- Treatment of Wernicke encephalopathy: 100-500 mg/day for 12-24 weeks 2
Critical timing: Administer thiamine BEFORE giving IV fluids containing glucose, as glucose administration can precipitate acute thiamine deficiency 2
Adjunctive Medications
For severe withdrawal not controlled by benzodiazepines alone:
- Carbamazepine: 200 mg PO every 6-8 hours (alternative for seizure prevention) 2
- Haloperidol: 0.5-5 mg PO/IM every 8-12 hours (use cautiously as adjunct ONLY for agitation or hallucinations not controlled by benzodiazepines) 2
Emerging evidence for phenobarbital: In moderate-to-severe AWS requiring hospital admission, phenobarbital added to benzodiazepines may reduce ICU length of stay and need for mechanical ventilation 5, 6
Supportive Care
Conservative management includes 2:
- Fluid resuscitation
- Electrolyte replacement (especially magnesium)
- Vitamins
- Comfortable, quiet environment
- Frequent vital sign monitoring
Special Populations
Patients with Cirrhosis
More than 70% of cirrhotic patients may not require benzodiazepines 7. When needed:
- Prefer short-acting benzodiazepines (lorazepam, oxazepam) to avoid accumulation 1, 4
- Use symptom-adapted dosing with careful monitoring 7
- Consider more gradual dose escalation 7
Note: The superiority of short-acting over long-acting benzodiazepines in hepatic insufficiency is not validated by controlled trials, and all benzodiazepines are affected by hepatic insufficiency 7
Monitoring Protocol
Outpatient monitoring: Daily assessment for up to 5 days after last drink to verify symptom improvement and evaluate need for additional treatment 3
Inpatient monitoring: Regular monitoring even without symptoms, which can be stopped after 24 hours if no specific signs appear 7
Long-Term Management
Psychiatric consultation is strongly recommended for evaluation, acute management, and long-term abstinence planning 2
Medications for alcohol use disorder should be initiated after withdrawal management 5, 8:
- Naltrexone: Prevents return to heavy drinking 5
- Acamprosate: Prevents return to heavy drinking and reduces heavy drinking 5
- Gabapentin: Reduces heavy drinking days and improves withdrawal symptoms 5
Common Pitfalls to Avoid
- Do not use CIWA-Ar alone for diagnosis - it can be falsely elevated in other conditions 2
- Do not give glucose before thiamine - this can precipitate Wernicke encephalopathy 2
- Do not continue benzodiazepines beyond 10-14 days - high abuse potential 1
- Do not use fixed-dose schedules - symptom-triggered dosing prevents drug accumulation 1
- Do not discharge without long-term treatment plan - withdrawal management alone is insufficient 2, 3